Detalhe da pesquisa
1.
Antibody evasion by the P.1 strain of SARS-CoV-2.
Cell
; 184(11): 2939-2954.e9, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852911
2.
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Cell
; 184(16): 4220-4236.e13, 2021 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242578
3.
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
Nat Immunol
; 24(7): 1161-1172, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322179
4.
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
; 586(7830): 578-582, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731258
5.
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Clin Infect Dis
; 76(2): 201-209, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36196614
6.
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Clin Exp Immunol
; 211(3): 280-287, 2023 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729167
7.
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Lancet
; 398(10304): 981-990, 2021 09 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480858
8.
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions.
Biotechnol Bioeng
; 119(10): 2784-2793, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822551
9.
Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
Biotechnol Bioeng
; 119(1): 48-58, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585736
10.
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature
; 590(7844): E24, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33469217
11.
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Lancet
; 396(10249): 467-478, 2020 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702298
12.
Modified Vaccinia Ankara-Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue.
J Infect Dis
; 222(5): 807-819, 2020 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740938
13.
Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.
J Infect Dis
; 219(8): 1187-1197, 2019 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407513
14.
Novel Bivalent Viral-Vectored Vaccines Induce Potent Humoral and Cellular Immune Responses Conferring Protection against Stringent Influenza A Virus Challenge.
J Immunol
; 2017 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724579
15.
Development of an objective gene expression panel as an alternative to self-reported symptom scores in human influenza challenge trials.
J Transl Med
; 15(1): 134, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28595644
16.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336730
17.
Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.
Malar J
; 14: 33, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25627033
18.
Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
Mol Ther
; 22(1): 233-8, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23831594
19.
Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Mol Ther
; 22(3): 668-674, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24374965
20.
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Mol Ther
; 22(11): 1992-2003, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24930599